Industry: Chemical & Material
Published Date: 2025-07-13
Pages: 97 Pages
Report ld: 4792400
Request Sample
Customized Report
UCMSCs Exosomes Market Size(US$)

CAGR 2025-2031
19.6%
Market Size,2031
USD 71.1
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for UCMSCs Exosomes was valued at US$ 21.9 million in the year 2024 and is projected to reach a revised size of US$ 71.1 million by 2031, growing at a CAGR of 19.6% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on UCMSCs Exosomes competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
UCMSCs exosomes are extracellular vesicles (about 30-150 nm in diameter) secreted from umbilical cord mesenchymal stem cells (UC-MSCs) that have similar bioactive substances as mother cells, but with lower immunogenicity and higher safety.
North American market for UCMSCs Exosomes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for UCMSCs Exosomes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of UCMSCs Exosomes include RoosterBio, Advancexo, EXO Biologics, Shenzhen Shifangjie Technology Co., Ltd., ZenBio, Kimera Labs, Guidon Pharmaceutics, Enze Kangtai, Beike Biotechnology, Creative Biolabs, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for UCMSCs Exosomes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding UCMSCs Exosomes.
The UCMSCs Exosomes market size, estimations, and forecasts are provided in terms of output/shipments (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global UCMSCs Exosomes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the UCMSCs Exosomes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
RoosterBio
Advancexo
EXO Biologics
Shenzhen Shifangjie Technology Co., Ltd.
ZenBio
Kimera Labs
Guidon Pharmaceutics
Enze Kangtai
Beike Biotechnology
Creative Biolabs
Paracrine Therapeutics
ExoQure
Aegle Therapeutics
Segment by Type
Protein-enriched Exosomes
Nucleic Acid-enriched Exosomes
Lipid-enriched Exosomes
Segment by Application
Regenerative Medicine
Anti-aging Treatment
Disease Treatment
Others
Production by Region
North America
Europe
China
Japan
India
Southeast Asia
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of UCMSCs Exosomes manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of UCMSCs Exosomes by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of UCMSCs Exosomes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 UCMSCs Exosomes Market Overview
1.1 Product Definition
1.2 UCMSCs Exosomes by Type
1.2.1 Global UCMSCs Exosomes Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Protein-enriched Exosomes
1.2.3 Nucleic Acid-enriched Exosomes
1.2.4 Lipid-enriched Exosomes
1.3 UCMSCs Exosomes by Application
1.3.1 Global UCMSCs Exosomes Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Regenerative Medicine
1.3.3 Anti-aging Treatment
1.3.4 Disease Treatment
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global UCMSCs Exosomes Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global UCMSCs Exosomes Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global UCMSCs Exosomes Production Estimates and Forecasts (2020-2031)
1.4.4 Global UCMSCs Exosomes Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global UCMSCs Exosomes Production Market Share by Manufacturers (2020-2025)
2.2 Global UCMSCs Exosomes Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of UCMSCs Exosomes, Industry Ranking, 2023 VS 2024
2.4 Global UCMSCs Exosomes Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global UCMSCs Exosomes Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of UCMSCs Exosomes, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of UCMSCs Exosomes, Product Offered and Application
2.8 Global Key Manufacturers of UCMSCs Exosomes, Date of Enter into This Industry
2.9 UCMSCs Exosomes Market Competitive Situation and Trends
2.9.1 UCMSCs Exosomes Market Concentration Rate
2.9.2 Global 5 and 10 Largest UCMSCs Exosomes Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 UCMSCs Exosomes Production by Region
3.1 Global UCMSCs Exosomes Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global UCMSCs Exosomes Production Value by Region (2020-2031)
3.2.1 Global UCMSCs Exosomes Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of UCMSCs Exosomes by Region (2026-2031)
3.3 Global UCMSCs Exosomes Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global UCMSCs Exosomes Production Volume by Region (2020-2031)
3.4.1 Global UCMSCs Exosomes Production by Region (2020-2025)
3.4.2 Global Forecasted Production of UCMSCs Exosomes by Region (2026-2031)
3.5 Global UCMSCs Exosomes Market Price Analysis by Region (2020-2025)
3.6 Global UCMSCs Exosomes Production and Value, Year-over-Year Growth
3.6.1 North America UCMSCs Exosomes Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe UCMSCs Exosomes Production Value Estimates and Forecasts (2020-2031)
3.6.3 China UCMSCs Exosomes Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan UCMSCs Exosomes Production Value Estimates and Forecasts (2020-2031)
3.6.5 India UCMSCs Exosomes Production Value Estimates and Forecasts (2020-2031)
3.6.6 Southeast Asia UCMSCs Exosomes Production Value Estimates and Forecasts (2020-2031)
4 UCMSCs Exosomes Consumption by Region
4.1 Global UCMSCs Exosomes Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global UCMSCs Exosomes Consumption by Region (2020-2031)
4.2.1 Global UCMSCs Exosomes Consumption by Region (2020-2025)
4.2.2 Global UCMSCs Exosomes Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America UCMSCs Exosomes Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America UCMSCs Exosomes Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe UCMSCs Exosomes Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe UCMSCs Exosomes Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific UCMSCs Exosomes Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific UCMSCs Exosomes Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa UCMSCs Exosomes Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa UCMSCs Exosomes Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global UCMSCs Exosomes Production by Type (2020-2031)
5.1.1 Global UCMSCs Exosomes Production by Type (2020-2025)
5.1.2 Global UCMSCs Exosomes Production by Type (2026-2031)
5.1.3 Global UCMSCs Exosomes Production Market Share by Type (2020-2031)
5.2 Global UCMSCs Exosomes Production Value by Type (2020-2031)
5.2.1 Global UCMSCs Exosomes Production Value by Type (2020-2025)
5.2.2 Global UCMSCs Exosomes Production Value by Type (2026-2031)
5.2.3 Global UCMSCs Exosomes Production Value Market Share by Type (2020-2031)
5.3 Global UCMSCs Exosomes Price by Type (2020-2031)
6 Segment by Application
6.1 Global UCMSCs Exosomes Production by Application (2020-2031)
6.1.1 Global UCMSCs Exosomes Production by Application (2020-2025)
6.1.2 Global UCMSCs Exosomes Production by Application (2026-2031)
6.1.3 Global UCMSCs Exosomes Production Market Share by Application (2020-2031)
6.2 Global UCMSCs Exosomes Production Value by Application (2020-2031)
6.2.1 Global UCMSCs Exosomes Production Value by Application (2020-2025)
6.2.2 Global UCMSCs Exosomes Production Value by Application (2026-2031)
6.2.3 Global UCMSCs Exosomes Production Value Market Share by Application (2020-2031)
6.3 Global UCMSCs Exosomes Price by Application (2020-2031)
7 Key Companies Profiled
7.1 RoosterBio
7.1.1 RoosterBio UCMSCs Exosomes Company Information
7.1.2 RoosterBio UCMSCs Exosomes Product Portfolio
7.1.3 RoosterBio UCMSCs Exosomes Production, Value, Price and Gross Margin (2020-2025)
7.1.4 RoosterBio Main Business and Markets Served
7.1.5 RoosterBio Recent Developments/Updates
7.2 Advancexo
7.2.1 Advancexo UCMSCs Exosomes Company Information
7.2.2 Advancexo UCMSCs Exosomes Product Portfolio
7.2.3 Advancexo UCMSCs Exosomes Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Advancexo Main Business and Markets Served
7.2.5 Advancexo Recent Developments/Updates
7.3 EXO Biologics
7.3.1 EXO Biologics UCMSCs Exosomes Company Information
7.3.2 EXO Biologics UCMSCs Exosomes Product Portfolio
7.3.3 EXO Biologics UCMSCs Exosomes Production, Value, Price and Gross Margin (2020-2025)
7.3.4 EXO Biologics Main Business and Markets Served
7.3.5 EXO Biologics Recent Developments/Updates
7.4 Shenzhen Shifangjie Technology Co., Ltd.
7.4.1 Shenzhen Shifangjie Technology Co., Ltd. UCMSCs Exosomes Company Information
7.4.2 Shenzhen Shifangjie Technology Co., Ltd. UCMSCs Exosomes Product Portfolio
7.4.3 Shenzhen Shifangjie Technology Co., Ltd. UCMSCs Exosomes Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Shenzhen Shifangjie Technology Co., Ltd. Main Business and Markets Served
7.4.5 Shenzhen Shifangjie Technology Co., Ltd. Recent Developments/Updates
7.5 ZenBio
7.5.1 ZenBio UCMSCs Exosomes Company Information
7.5.2 ZenBio UCMSCs Exosomes Product Portfolio
7.5.3 ZenBio UCMSCs Exosomes Production, Value, Price and Gross Margin (2020-2025)
7.5.4 ZenBio Main Business and Markets Served
7.5.5 ZenBio Recent Developments/Updates
7.6 Kimera Labs
7.6.1 Kimera Labs UCMSCs Exosomes Company Information
7.6.2 Kimera Labs UCMSCs Exosomes Product Portfolio
7.6.3 Kimera Labs UCMSCs Exosomes Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Kimera Labs Main Business and Markets Served
7.6.5 Kimera Labs Recent Developments/Updates
7.7 Guidon Pharmaceutics
7.7.1 Guidon Pharmaceutics UCMSCs Exosomes Company Information
7.7.2 Guidon Pharmaceutics UCMSCs Exosomes Product Portfolio
7.7.3 Guidon Pharmaceutics UCMSCs Exosomes Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Guidon Pharmaceutics Main Business and Markets Served
7.7.5 Guidon Pharmaceutics Recent Developments/Updates
7.8 Enze Kangtai
7.8.1 Enze Kangtai UCMSCs Exosomes Company Information
7.8.2 Enze Kangtai UCMSCs Exosomes Product Portfolio
7.8.3 Enze Kangtai UCMSCs Exosomes Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Enze Kangtai Main Business and Markets Served
7.8.5 Enze Kangtai Recent Developments/Updates
7.9 Beike Biotechnology
7.9.1 Beike Biotechnology UCMSCs Exosomes Company Information
7.9.2 Beike Biotechnology UCMSCs Exosomes Product Portfolio
7.9.3 Beike Biotechnology UCMSCs Exosomes Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Beike Biotechnology Main Business and Markets Served
7.9.5 Beike Biotechnology Recent Developments/Updates
7.10 Creative Biolabs
7.10.1 Creative Biolabs UCMSCs Exosomes Company Information
7.10.2 Creative Biolabs UCMSCs Exosomes Product Portfolio
7.10.3 Creative Biolabs UCMSCs Exosomes Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Creative Biolabs Main Business and Markets Served
7.10.5 Creative Biolabs Recent Developments/Updates
7.11 Paracrine Therapeutics
7.11.1 Paracrine Therapeutics UCMSCs Exosomes Company Information
7.11.2 Paracrine Therapeutics UCMSCs Exosomes Product Portfolio
7.11.3 Paracrine Therapeutics UCMSCs Exosomes Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Paracrine Therapeutics Main Business and Markets Served
7.11.5 Paracrine Therapeutics Recent Developments/Updates
7.12 ExoQure
7.12.1 ExoQure UCMSCs Exosomes Company Information
7.12.2 ExoQure UCMSCs Exosomes Product Portfolio
7.12.3 ExoQure UCMSCs Exosomes Production, Value, Price and Gross Margin (2020-2025)
7.12.4 ExoQure Main Business and Markets Served
7.12.5 ExoQure Recent Developments/Updates
7.13 Aegle Therapeutics
7.13.1 Aegle Therapeutics UCMSCs Exosomes Company Information
7.13.2 Aegle Therapeutics UCMSCs Exosomes Product Portfolio
7.13.3 Aegle Therapeutics UCMSCs Exosomes Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Aegle Therapeutics Main Business and Markets Served
7.13.5 Aegle Therapeutics Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 UCMSCs Exosomes Industry Chain Analysis
8.2 UCMSCs Exosomes Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 UCMSCs Exosomes Production Mode & Process Analysis
8.4 UCMSCs Exosomes Sales and Marketing
8.4.1 UCMSCs Exosomes Sales Channels
8.4.2 UCMSCs Exosomes Distributors
8.5 UCMSCs Exosomes Customer Analysis
9 UCMSCs Exosomes Market Dynamics
9.1 UCMSCs Exosomes Industry Trends
9.2 UCMSCs Exosomes Market Drivers
9.3 UCMSCs Exosomes Market Challenges
9.4 UCMSCs Exosomes Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global UCMSCs Exosomes market is projected to grow from US$ 24.3 million in 2025 to US$ 83.67 million by 2032, at a CAGR of 19.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-12
Pages: 152
USD 4900.00
(Single User License)
The global UCMSCs Exosomes market size was US$ 24.3 million in 2025 and is forecast to reach a readjusted size of US$ 83.67 million by 2032 with a CAGR of 19.6% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 93
USD 4250.00
(Single User License)
The global UCMSCs Exosomes market was valued at US$ 24.3 million in 2025 and is anticipated to reach US$ 83.67 million by 2032, at a CAGR of 19.6% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 145
USD 2900.00
(Single User License)
The global market for UCMSCs Exosomes was estimated to be worth US$ 24.3 million in 2025 and is projected to reach US$ 83.67 million, growing at a CAGR of 19.6% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 129
USD 3950.00
(Single User License)
The global UCMSCs Exosomes market is projected to grow from US$ 21.9 million in 2024 to US$ 71.1 million by 2031, at a CAGR of 19.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-13
Pages: 167
USD 4900.00
(Single User License)
The global market for UCMSCs Exosomes was estimated to be worth US$ 21.9 million in 2024 and is forecast to a readjusted size of US$ 71.1 million by 2031 with a CAGR of 19.6% during the forecast period 2025-2031.
Published Date: 2025-07-13
Pages: 113
USD 3950.00
(Single User License)
The global UCMSCs Exosomes market size was US$ 21.9 million in 2024 and is forecast to a readjusted size of US$ 71.1 million by 2031 with a CAGR of 19.6% during the forecast period 2025-2031.
Published Date: 2025-07-13
Pages: 96
USD 4250.00
(Single User License)
The global UCMSCs Exosomes market is projected to grow from US$ 24.3 million in 2025 to US$ 83.67 million by 2032, at a CAGR of 19.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 152
The global UCMSCs Exosomes market size was US$ 24.3 million in 2025 and is forecast to reach a readjusted size of US$ 83.67 million by 2032 with a CAGR of 19.6% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 93
The global UCMSCs Exosomes market was valued at US$ 24.3 million in 2025 and is anticipated to reach US$ 83.67 million by 2032, at a CAGR of 19.6% from 2026 to 2032.
Published: 2026-03-12
Pages: 145
The global market for UCMSCs Exosomes was estimated to be worth US$ 24.3 million in 2025 and is projected to reach US$ 83.67 million, growing at a CAGR of 19.6% from 2026 to 2032.
Published: 2026-03-09
Pages: 129
The global UCMSCs Exosomes market is projected to grow from US$ 21.9 million in 2024 to US$ 71.1 million by 2031, at a CAGR of 19.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-13
Pages: 167
The global market for UCMSCs Exosomes was estimated to be worth US$ 21.9 million in 2024 and is forecast to a readjusted size of US$ 71.1 million by 2031 with a CAGR of 19.6% during the forecast period 2025-2031.
Published: 2025-07-13
Pages: 113
The global UCMSCs Exosomes market size was US$ 21.9 million in 2024 and is forecast to a readjusted size of US$ 71.1 million by 2031 with a CAGR of 19.6% during the forecast period 2025-2031.
Published: 2025-07-13
Pages: 96
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now